The healthcare industry is still grappling with supply disruptions, and experts predict these challenges will persist in 2025, according to the American Hospital Association’s 2025 Environmental Scan report.
The FDA announced that IV fluid containers of all sizes have been added to its medical device shortages list, with the shortage expected to persist through March 2025.
Throughout his campaign and time as President-elect, Donald Trump has issued several proposals regarding the U.S. supply chain, from plans to raise tariffs up to 100% for certain countries to a complete restructuring of the global supply chain.
President-elect Donald Trump plans to implement new tariffs against Canada, Mexico and China, three of America’s leading trading partners, in a post on social media network Truth Social.
Baxter has implemented new allocation levels for several U.S. IV product groups, effective Nov. 26, as part of recovery efforts at its North Carolina manufacturing site.
President-elect Donald Trump’s plan to impose tariffs on imported goods is expected to affect the prices of approximately 75% of medical devices marketed in the U.S., according to consulting firm GlobalData’s Medsource Database, Medical Device Network …
The FDA’s Center for Devices and Radiological Health announced a pilot program designed to improve the timeliness of communications regarding high-risk medical device recalls.
Baxter announced the release of its first 1-liter IV solutions manufactured post-hurricane, marking a significant step in addressing the ongoing IV shortage.